Our Bureau, Mumbai Tuesday, March 18, 2025, 16:30 Hrs [IST] ...

Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, ...

"He eventually muttered, 'You're right, everyone's always been right. I can't believe I got to this point' and kept bawling ...

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

Good afternoon, and welcome to the Evoke Pharma fourth quarter and full-year 2024 earnings conference call. (Operator Instructions) Please be advised that today's call is being recorded. I would now ...

ENCell Co., Ltd., a South Korean biotech specializing in advanced biopharmaceutical contract development and manufacturing organizations (CDMO) and novel drug development, has signed an MOU for ...

Evoke Pharma, Inc. ( NASDAQ: EVOK) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Daniel Kontoh-Boateng – DKB Partners Matt D’Onofrio – Chief Executive Officer Chris Quesenberry – Chief ...

SOLANA BEACH, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical ...

World Sleep Society calls for sleep health advocates worldwide to promote the power of healthy sleep on World Sleep Day this Friday, ...

Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support ...